TABLE 2.
Farm prevalence of ESBL and colistin resistance genes.
| P Isolates group | C Isolates group | NC Isolates group | Summary | |||||||||
| Resistance prevalence | SSF | MSF | Total within sample group | SSF | MSF | Total within sample group | SSF | MSF | Total within sample group | Total within small-scale farms | Total within medium-scale farms | Overall total |
| ESBL | (94/95) 98.9% | (47/48) 97.9% | (141/143) 98.6% | (59/61) 96.7% | (28/29) 96.6% | (87/90) 96.7% | (40/41) 97.6% | (13/13) 100% | (53/54) 98.2% | (106/107) 99.1% | (49/49) 100% | (155/156) 99.4% |
| Colistin | (59/95) 62.1% | (4/48) 8.3% | (63/143) 44.1% | (25/61) 41.0% | (4/29) 13.8% | (29/90) 32.2% | (11/41) 26.83% | (4/13) 30.8% | (15/54) 27.8% | (66/107) 6 1.7% | (10/49) 20.4% | (76/156) 48.7% |